Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus–associated lesions as a marker for progression to malignancy
The DOI matches its Crossref record.
Abstract
High‐risk HPVs play a causal role in the development of cervical cancer, and their E6 oncoproteins target h‐Dlg for ubiquitin‐mediated proteolysis. The h‐Dlg oncosuppressor is associated with cell–cell interactions, and deregulation of these structures leads to defective cell adhesion, loss of cell polarity and unregulated proliferation. We evaluated the contribution of this E6 activity in the progression to malignancy in HPV infections by analyzing h‐Dlg expression in HPV‐associated lesions. We analyzed h‐Dlg in cervical, laryngeal, vulvar, colon and kidney histologic samples by Dlg immunohistochemistry. HPV association was ascertained by a PCR‐colorimetric method. Although Dlg was certainly expressed in intraepithelial cervical, vulvar and laryngeal HPV‐associated lesions, its cellular and tissue distribution patterns were altered compared to normal tissue. However, marked reduction in Dlg levels was observed in HPV‐positive invasive cervical carcinomas. To elucidate whether the loss of Dlg was significant for carcinogenesis in general, we investigated Dlg expression in tumors not associated with HPV. In colon and kidney carcinomas, Dlg was expressed, albeit with a different pattern of distribution with respect to the normal tissue. The loss of Dlg may be considered a late‐stage marker in cervical carcinogenesis, but alterations in its expression and localization take place during the different dysplastic stages. Dlg downregulation and/or alterations in its localization may contribute to transformation and may explain some of the characteristics of the malignant cells, such as loss of polarity and high migration ability. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cell polarity in development and cancer
Wodarz, A., & Näthke, I. (2007) · Nature Cell Biology · doi:10.1038/ncb433 · Cited by 395
Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module
Humbert, P. O., Grzeschik, N. A., Brumby, A. M., Galea, R., Elsum, I., & Richardson, H. E. (2008) · Oncogene · doi:10.1038/onc.2008.341 · Cited by 318
Polarity proteins in migration and invasion
Etienne-Manneville, S. (2008) · Oncogene · doi:10.1038/onc.2008.347 · Cited by 295
Cell polarity and cancer – cell and tissue polarity as a non-canonical tumor suppressor
Lee, M., & Vasioukhin, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.016634 · Cited by 276
Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses
Javier, R. T., & Rice, A. P. (2011) · Journal of Virology · doi:10.1128/jvi.05410-11 · Cited by 198
“cancers, and E6 PBM-mediated degradation of these two polarity proteins may 235 therefore contribute to carcinogenesis (8, 72, 115, 123).”
BackgroundDow, L. E., Kauffman, J. S., Caddy, J., Peterson, A. S., Jane, S. M., Russell, S. M., & Humbert, P. O. (2007) · Oncogene · doi:10.1038/sj.onc.1210016 · Cited by 187
“Studies in a number of different human cancers have now shown that loss of Scribble and Dlg is associated with more invasive and aggressive malignancies (Watson et al., 2002; Boussioutas et al., 2003; Cavatorta et al., 2004; Lin et al., 2004; Nakagawa et al., 2004; Navarro et al., 2005; Gardiol et al., 2006).”
BackgroundPearson, H. B., Perez-Mancera, P. A., Dow, L. E., Ryan, A., Tennstedt, P., Bogani, D., Elsum, I., Greenfield, A., Tuveson, D. A., Simon, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58509 · Cited by 185
Human papillomaviruses, cervical cancer and cell polarity
Thomas, M., Narayan, N., Pim, D., Tomaić, V, Massimi, P., Nagasaka, K., Kranjec, C., Gammoh, N., & Banks, L. (2008) · Oncogene · doi:10.1038/onc.2008.351 · Cited by 163
Self-citationStephens, R., Lim, K., Portela, M., Kvansakul, M., Humbert, P. O., & Richardson, H. E. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.011 · Cited by 132
Thomas, M., Massimi, P., Navarro, C., Borg, J.-P., & Banks, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208757 · Cited by 117
Self-citationViral Interactions with PDZ Domain-Containing Proteins—An Oncogenic Trait?
James, C., & Roberts, S. (2016) · Pathogens · doi:10.3390/pathogens5010008 · Cited by 83
The stability of the human papillomavirus E6 oncoprotein is E6AP dependent
Tomaić, V., Pim, D., & Banks, L. (2009) · Virology · doi:10.1016/j.virol.2009.07.029 · Cited by 76
Self-citationThe E6 Oncoprotein from HPV16 Enhances the Canonical Wnt/β-Catenin Pathway in Skin Epidermis In Vivo
Bonilla-Delgado, J., Bulut, G., Liu, X., Cortés-Malagón, E. M., Schlegel, R., Flores-Maldonado, C., Contreras, R. G., Chung, S.-H., Lambert, P. F., Üren, A., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0287 · Cited by 50
Metadata
- Authors
- Cavatorta, A. L., Fumero, G., Chouhy, D., Aguirre, R., Nocito, A. L., Giri, A. A., Banks, L., & Gardiol, D.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2004-04-23
- Volume
- 111
- Issue
- 3
- Pages
- 373-380
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1990759138
- Cited by
- 77
- References
- 0
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.